In patients with multiple myeloma, the percentage of people alive after seven years is the same whether they take lenalidomide for two years or for as long as they live.
See the scientific wording
Among patients with multiple myeloma, 7-year overall survival rates following two years of lenalidomide therapy are equivalent to those following indefinite lenalidomide therapy.
Very strong evidence
Randomized trialsOne high-quality study supports this claim.
What the research says
1 study reviewedSupporting (1)
Continuous versus Fixed Duration Maintenance Therapy in Multiple Myeloma
Randomized Controlled TrialHuman2026
After seven years, almost the same number of patients were alive whether they took lenalidomide for just two years or for the rest of their lives — the difference was so small it could be due to chance.
Contradicting (0)
No contradicting studies found yet
That doesn't mean it's settled — it just means no study has tested the opposite.
Quality-weighted scoring: we follow the GRADE framework — each study is rated High, Moderate, Low, or Very Low based on study design, methodology rigor, and risk of bias. A single high-quality RCT can outweigh several weaker observational studies.
Scores reflect study quality, not just count.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting study
How Fit Body Science checks a claim
- 1
We isolate the claim
Health advice from videos, articles and studies is broken down into single, testable claims.
- 2
We find the research
Each claim is matched against peer-reviewed studies, with every source cited by DOI.
- 3
We grade the evidence
Studies are scored on methodology, statistical rigor, transparency and publication quality.
The fitness and health internet is full of confident claims. We check them against real research.
Every claim on this site is traced back to peer-reviewed studies, scored on methodology and reporting quality, and given a verdict you can audit yourself — sources, DOIs and all.
- Full evidence breakdown and mechanism chains
- Ask our AI anything about a claim or its studies
- Get notified when new research changes a verdict